IBRX · Insider Trading
ImmunityBio, Inc. Common Stock
Every open-market purchase and sale reported by IBRX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Barry J. Simon | Director | Sell | −25,000 | −$268.76K |
| 2026-10-06 | Cheryl Cohen | Director | MIXED | −25,077 | −$684.27K |
| 2026-07-06 | Christobel Selecky | Director | MIXED | — | −$962.58K |
| 2026-07-06 | Cheryl Cohen | Director | MIXED | −75,231 | −$1.08M |
| 2026-07-01 | Christobel Selecky | Director | MIXED | — | −$586.85K |
| 2026-06-26 | Barry J. Simon | Director | Sell | −25,000 | −$196.91K |
| 2026-06-10 | Wesley Clark | Director | A | +65,600 deriv. | — |
| 2026-06-10 | Cheryl Cohen | Director | A | +65,600 deriv. | — |
| 2026-06-10 | Michael D Blaszyk | Director | A | +65,600 deriv. | — |
| 2026-06-10 | Linda Maxwell | Director | A | +65,600 deriv. | — |
| 2026-06-10 | Christobel Selecky | Director | A | +65,600 deriv. | — |
| 2026-06-10 | Bruce Wendel | Director | A | +65,600 deriv. | — |
| 2026-06-05 | Barry J. Simon | Director | Sell | −23,033 | −$165.31K |
| 2026-04-02 | MP 13 Ventures, LLC | 10%+ Owner | C | +23,032,980 | +$125.00M |
| 2026-02-26 | Barry J. Simon | Director | Sell | −75,000 | −$900.79K |
| 2026-02-24 | Regan J Lauer | Chief Accounting Officer | MIXED | +2,392 | −$14.56K |
| 2026-02-24 | David C. Sachs | Chief Financial Officer | MIXED | +19,968 | −$179.93K |
| 2026-02-24 | Barry J. Simon | Director | MIXED | −165,783 | −$1.84M |
| 2026-02-24 | Richard Adcock | CEO & President | MIXED | +74,879 | −$674.77K |
| 2026-02-24 | Christobel Selecky | Director | MIXED | — | −$175.50K |
| 2026-02-24 | Nant Capital, LLC | 10%+ Owner | MIXED | +280,795 | −$2.53M |
| 2026-02-12 | Regan J Lauer | Chief Accounting Officer | MIXED | +3,225 | −$15.64K |
| 2026-02-12 | Richard Adcock | CEO & President | MIXED | +134,074 | −$970.53K |
| 2026-02-12 | David C. Sachs | Chief Financial Officer | MIXED | +39,593 | −$295.52K |
| 2026-02-12 | Patrick Soon-Shiong | See remarks | MIXED | +777,810 | −$4.11M |
| 2026-01-21 | Barry J. Simon | Director | Sell | −151,967 | −$1.09M |
| 2026-01-21 | Christobel Selecky | Director | MIXED | — | −$214.15K |
| 2026-01-05 | Richard Adcock | CEO & President | MIXED | +16,973 | −$34.67K |
| 2026-01-05 | David C. Sachs | Chief Financial Officer | MIXED | +14,962 | −$30.56K |
| 2025-12-16 | Bruce Wendel | Director | A | +146,020 deriv. | — |
| 2025-06-20 | Christobel Selecky | Director | A | +162,786 deriv. | — |
| 2025-06-20 | Michael D Blaszyk | Director | A | +162,786 deriv. | — |
| 2025-06-20 | Wesley Clark | Director | A | +162,786 deriv. | — |
| 2025-06-20 | Linda Maxwell | Director | A | +162,786 deriv. | — |
| 2025-06-20 | Cheryl Cohen | Director | A | +162,786 deriv. | — |
| 2025-02-25 | David C. Sachs | Chief Financial Officer | MIXED | +24,790 | −$54.24K |
| 2025-02-25 | Barry J. Simon | Director | MIXED | +9,790 | −$18.65K |
| 2025-02-25 | Richard Adcock | CEO & President | MIXED | +74,272 | −$267.33K |
| 2025-02-25 | Regan J Lauer | Chief Accounting Officer | MIXED | +2,396 | −$5.71K |
| 2025-02-25 | Nant Capital, LLC | 10%+ Owner | MIXED | +361,290 | −$719.41K |
| 2025-02-12 | David C. Sachs | Chief Financial Officer | A | +1,090,460 deriv. | — |
| 2025-02-12 | Patrick Soon-Shiong | See remarks | A | +3,634,868 deriv. | — |
| 2025-02-12 | Regan J Lauer | Chief Accounting Officer | A | +72,697 deriv. | — |
| 2025-02-12 | Richard Adcock | CEO & President | A | +3,634,868 deriv. | — |
| 2025-01-24 | Barry J. Simon | Director | M | +110,020 | +$219.86K |
| 2025-01-03 | David C. Sachs | Chief Financial Officer | MIXED | +14,992 | −$39.44K |
| 2025-01-03 | Richard Adcock | CEO & President | MIXED | +17,008 | −$44.74K |
| 2024-12-16 | Regan J Lauer | Chief Accounting Officer | MIXED | +13,528 | −$21.53K |
| 2024-12-12 | MP 13 Ventures, LLC | 10%+ Owner | C | +585,926,300 | +$1.16B |
| 2024-06-13 | John Owen Brennan | Director | A | +77,633 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Patrick Soon-Shiong | See remarks | 291,526,126 | $2.28B |
| MP 13 Ventures, LLC | 10%+ Owner | 77,315,845 | $603.84M |
| Nant Capital, LLC | 10%+ Owner | 39,803,001 | $310.86M |
| Barry J. Simon | Director | 2,777,788 | $21.69M |
| Richard Adcock | CEO & President | 562,274 | $4.39M |
| David C. Sachs | Chief Financial Officer | 320,825 | $2.51M |
| Michael D Blaszyk | Director | 265,582 | $2.07M |
| Cheryl Cohen | Director | 181,365 | $1.42M |
| Regan J Lauer | Chief Accounting Officer | 117,548 | $918.05K |
| Christobel Selecky | Director | 35,064 | $273.85K |
| Wesley Clark | Director | 8,000 | $62.48K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IBRX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.